Correspondence 0001213900-24-059038 from La Rosa Holdings Corp. (LRHC)
La Rosa Holdings Corp.
Date: July 3, 2024 · CIK: 0001879403 · Accession: 0001213900-24-059038
AI Filing Summary & Sentiment
File numbers found in text: 333-278901
Show Raw Text
CORRESP
1
filename1.htm
July 3, 2024
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Real Estate & Construction
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Mr. Benjamin Holt/ Ms. Dorrie Yale
Re:
La Rosa Holdings Corp.
Amendment No. 1 to Registration Statement on Form S-1
Filed June 4, 2024
File No. 333-278901
Dear Mr. Holt and Ms. Yale:
On behalf of La Rosa Holdings Corp. (the “Company”),
we have set forth below responses to the comments of the staff (the “Staff”) of the Securities and Exchange Commission
(the “SEC”) contained in its letter, dated June 27, 2024, regarding the Company’s Amendment No. 1 to the Registration
Statement on Form S-1 (the “Form S-1”) as noted above.
For your convenience, the text of the Staff’s
comments is set forth below in bold, followed in each case by the Company’s responses. Please note that all references to page numbers
in the responses are references to the page numbers in Amendment No. 2 to the Form S-1 (the “S-1/A”) submitted concurrently
with the submission of this letter in response to the Staff’s comments. All capitalized terms used but not defined herein shall
have the meanings ascribed to them in the S-1/A.
Amendment No. 1 to the Registration Statement
on Form S-1 filed June 4, 2024
General
1. We acknowledge your response to our prior comment. Please tell us how you have determined to register
up to 7,734,221 shares of common stock issuable upon conversion of the convertible promissory notes. In this regard, we note that the
promissory note issued in February 2024 was in the face amount of $1,052,631.58 and that the promissory note issued in April 2024 was
in the face amount of $1,316,000, each with a conversion price of $2.50.
Response:
Please be advised that the Company has recalculated
and amended the total number of shares of common stock issuable upon conversion of the convertible promissory notes to an aggregate of
2,504,519 shares. This amended number of shares is derived from the aggregate of shares issuable upon conversion of two specific notes:
1) 1,119,630 shares of common stock for the February 2024 convertible promissory note (the “February Note”), and 2)
1,384,889 shares of common stock for the April 2024 convertible promissory note (the “April Note”).
Under the terms of the Registration Rights Agreements
between the Company and the Selling Stockholder in connection with both notes, the Company is obligated to register the “Conversion
Shares,” defined in the Securities Purchase Agreements as “the shares issuable upon the conversion [of the notes].”
1185 AVENUE OF THE AMERICAS | 31ST FLOOR | NEW
YORK, NY | 10036 T (212) 930-9700 | F (212) 930-9725 | WWW.SRFC.LAW
Pursuant to the terms of each note, the conversion
price of $2.50 per share (the “Conversion Price”) is subject to adjustment in the event the Company fails to pay an
Amortization Payment (as defined in the notes) when due under the respective notes. Each note states that in the event the Company fails
to make an amortization payment, the Conversion Price of the note is adjusted to be the lesser of (i) the then applicable
Conversion Price; or (ii) the Market Price, defined in each note as 85% of the lowest Volume Weighted Average Price (VWAP) recorded on
any trading day in the five trading days preceding the conversion date of the respective note. According to the notes, “VWAP”
is calculated as the volume-weighted average price of the Company’s common stock on Nasdaq from 9:30 a.m. to 4:00 p.m., New York time.
On July 1, 2024, the VWAP of the Company’s
common stock on Nasdaq was $1.5469 per share, thereby setting the Market Price at $1.314865 per share, which is 85% of the VWAP. The outstanding
principal and accrued interest on the February Note, as of July 1, 2024, was $1,101,369.88. With the Market Price set at $1.314865 per
share, the conversion of the February Note would result in the issuance of 1,119,630 shares of common stock. Similarly, as of July 1,
2024, the April Note’s total outstanding principal amount and accrued interest of $1,357,715.4. Using the same Market Price, the conversion
of the April Note would result in the issuance of 1,384,889 shares of common stock.
The Company used the “Market Price”
in recalculating the number of shares of common stock to be registered on the S-1/A in relation to the notes to ensure its contractual
obligations to register the “Conversion Shares” under the terms of the Registration Rights Agreements.
Subsequent to identifying the miscalculation and
updating the number of shares of common stock issuable under the notes based on the Market Price calculated based on 85% of the VWAP reported
by Nasdaq on July 1, 2024, the Company has accordingly updated the information regarding the shares issuable upon conversion of the notes
in the S-1/A.
Plan of Distribution, page 22
2. We note your disclosure that the Selling Stockholder may sell their securities in transactions through
broker-dealers, including ones where the broker-dealer agrees with the Selling Stockholder to sell a specified number of such securities
at a stipulated price per security. Please confirm your understanding that the retention by the Selling Stockholder of an underwriter
would constitute a material change to your plan of distribution requiring a post-effective amendment. Refer to your undertaking provided
pursuant to Item 512(a)(1)(iii) of Regulation S-K.
Response:
The Company hereby confirms that the retention
by the Selling Stockholder of an underwriter would constitute a material change to the Company’s plan of distribution requiring
a post-effective amendment to the Form S-1 pursuant to Item 512(a)(1)(iii) of Regulation S-K.
We trust that the above is responsive to your
comments.
Should you have any questions relating to the
foregoing or wish to discuss any aspect of the Company’s filing, please contact me at 646-838-1310.
Sincerely,
/s/ Ross Carmel
Ross Carmel, Esq.
Sichenzia Ross Ference Carmel LLP
1185 AVENUE OF THE AMERICAS | 31ST FLOOR | NEW
YORK, NY | 10036 T (212) 930-9700 | F (212) 930-9725 | WWW.SRFC.LAW